chr7-150737553-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001199577.2(GIMAP1-GIMAP5):c.451G>A(p.Val151Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000358 in 1,535,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001199577.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIMAP1-GIMAP5 | NM_001199577.2 | c.451G>A | p.Val151Ile | missense_variant | 4/6 | NP_001186506.1 | ||
GIMAP5 | NM_018384.5 | c.-162G>A | 5_prime_UTR_variant | 1/3 | ENST00000358647.5 | NP_060854.2 | ||
GIMAP1-GIMAP5 | NM_001303630.2 | c.67G>A | p.Val23Ile | missense_variant | 3/5 | NP_001290559.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GIMAP5 | ENST00000358647.5 | c.-162G>A | 5_prime_UTR_variant | 1/3 | 1 | NM_018384.5 | ENSP00000351473 | P1 | ||
GIMAP5 | ENST00000498181.6 | c.-162G>A | 5_prime_UTR_variant | 2/4 | 4 | ENSP00000487840 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152094Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000191 AC: 25AN: 130636Hom.: 0 AF XY: 0.000224 AC XY: 16AN XY: 71328
GnomAD4 exome AF: 0.000372 AC: 515AN: 1383402Hom.: 0 Cov.: 31 AF XY: 0.000330 AC XY: 225AN XY: 682604
GnomAD4 genome AF: 0.000223 AC: 34AN: 152212Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74418
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at